Presence of glandular cells at pre-operative cervical cytology in endometrial cancer patients: implications on tumor histology and survival
2012-01-01 Bogani, Giorgio; Uccella, Silvia; Foementi, G; Cromi, Antonella; Casarin, Jvan; Donadello, N; Apolloni, C; Ghezzi, Fabio
Allelotyping analysis of gastroenteropancreatic endocrine tumors
2003-01-01 Furlan, D; Cerutti, R; Genasetti, A; Uccella, S; La Rosa, S; Capella, C
Detection of Foetal Microchimerism in Thyroid Disease
2004-01-01 Bernasconi, B; Uccella, Silvia; Bartalena, Luigi; Procopio, Fm; Accolla, Roberto; Capella, CARLO RENATO; Sessa, Fausto
Ribonuclease T2 (RNASET2) expression in the spectrum of neuroendocrine neoplasms of the lung. Relationships with hypoxia-related mechanisms and microvascular patterns
2018-01-01 Maragliano, R; Scaldaferri, D; Monti, L; Sorrenti, E; Gariboldi, M; Taramelli, R; Sessa, F; Acquati, F; La Rosa, S; Uccella, S
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells
2019-01-01 Amodio, V; Grmano, G; Barault, L; Lamba, S; Rospo, G; Magri, A; Maione, F; Crisafulli, G; Cancelliere, C; Lerda, G; Bartolini, A; Siravegna, G; Mussolin, B; Frappolli, R; Montone, M; Randon, G; de Braud, F; Angelozzi, Na; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Satore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A
microRNA-181a plays a critical role in ovarian cancer progression through the regulation of epithelial-mesenchymal transition
2013-01-01 Parikh, A; Lee, C; Joseph, P; Marchini, S; Baccarini, A; Kolev, V; Romualdi, C; Fruscio, R; Shah, H; Feng, W; Mullokandov, G; Fishman, D; D'Incalci, M; Rahaman, J; Kalir, T; Redline, R; Brown, Bd; Narla, G; Difeo, A
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations
2014-01-01 Algeri, M; Rosti, V; Zecca, M; Erba, E; Aronica, A; Galli, A; Zambelli, A; Strocchio, L; Tolva, A; Quartuccio, G; Mina, T; D'Incalci, M; DELLA PORTA, MATTEO GIOVANNI
Lurbinectedin (PM01183): Antineoplastic Activity in Murine and Human Experimental Models
2012-01-01 Fraoolli, R; Bello, E; Zangarini, M; Zucchetti, P; Aviles, P; D'Incalci, M
HMGA1 is a new biomarker of liposarcoma progression
2017-01-01 Loria, R; Laquintana, V; Bon, G; Trisciuoglio, D; Covello, R; Amoreo, Ca; Ferraresi, V; Zoccali, C; D'Incalci, M; Biagini, R; Falcioni, R
Alpha 1 acid glycoprotein (AGP) binds to STI571 and substantially alters its pharmacokinetics in chronic myeloid leukemia (CML) patients
2001-01-01 Gambacorti-Passeri, C; Zucchetti, M; Frapolli, R; Russo, D; Rossi, F; Pogliani, E; Corneo, G; Tornaghi, L; Alberti, D; D'Incalci, M
Evaluation of the pan-BET-bromodomain inhibitor OTX015 as a single agent and in combination with everolimus (RAD001) in triple-negative breast cancer
2014-01-01 Vazquez, R; Astorgues-Xerri, L; Riveiro, Me; Di Marino, M; Beltrame, L; Bekradda, M; Cvitkovic, E; Erba, E; Frapolli, R; D'Incalci, M
SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY
2013-01-01 Tancredi, R; Negri, S; Cattrini, C; Ponchio, L; Frascaroli, M; Daprada, G; Fregoni, V; Pavesi, L; Riccardi, A; Zucchetti, M; D'Incalci, M; Zambelli, A
Induction of resistance to Aplidin((R)) in a human ovarian cancer cell line related to MDR expression
2006-01-01 Tognon, G; Bernasconi, S; Celli, N; Faircloth, Gt; Cuevas, C; Jimeno, J; D'Incalci, M; Erba, E
Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM)
2015-01-01 Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P
miRNA landscape analysis of stage I EOC, identifies miR-199a-5p associated to poor prognosis in grade 3 subgroup
2013-01-01 Calura, E; Fruscio, R; Paracchini, L; Bignotti, E; Martini, P; Ravaggi, A; Di Marino, M; Sales, G; Beltrame, L; Dell'Orto, F; Baldo, R; Pecorelli, S; Sartori, E; Zanotti, L; Katsaros, D; Tognon, G; D'Incalci, M; Romualdi, C; Marchini, S
EPOC-experiences - conducting a multinational clinical trial on the pharmacology of doxorubicin in children with cancer
2013-01-01 Krischke, M; Andre, N; Boddy, A; Bode, G; D'Incalci, M; Hempel, G; Kontny, N; Steel, A; Voller, V; Boos, J
Pharmacokinetics of concomitant cisplatin and paclitaxel administration by hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis
2013-01-01 Ansaloni, L; Busci, Lm; Coccolini, F; Grosso, G; Lotti, M; Morosi, L; Poiasina, E; Zucchetti, M; D'Incalci, M; Frigerio, L
RANDOMIZED, NON-COMPARATIVE, PHASE II TRIAL OF BEVACIZUMAB AND TRABECTEDIN WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE OVARIAN CANCER (ROC) WOMEN
2017-01-01 Colombo, N; Nicoletto, Mo; Lissoni, A; Scambia, G; Tognon, G; Negri, E; Galli, F; Biagioli, E; Rulli, E; Fossati, R; D'Incalci, M
AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER
2014-01-01 Gerardi, C; Floriani, I; Biagioli, E; D'Incalci, M; Fossati, R; Colombo, N
Fsn0503h antibody-mediated blockade of cathepsin S as potential therapeutic strategy for the treatment of solid tumors
2013-01-01 Vazquez, R; Astorgues-Xerri, L; Cvitkovic, E; Bekradda, M; Fleck, R; Gormley, J; Buick, R; Kerr, P; Raymond, E; D'Incalci, M; Frapolli, R; Riveiro, Me
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Presence of glandular cells at pre-operative cervical cytology in endometrial cancer patients: implications on tumor histology and survival | 1-gen-2012 | Bogani, Giorgio; Uccella, Silvia; Foementi, G; Cromi, Antonella; Casarin, Jvan; Donadello, N; Apolloni, C; Ghezzi, Fabio | |
| Allelotyping analysis of gastroenteropancreatic endocrine tumors | 1-gen-2003 | Furlan, D; Cerutti, R; Genasetti, A; Uccella, S; La Rosa, S; Capella, C | |
| Detection of Foetal Microchimerism in Thyroid Disease | 1-gen-2004 | Bernasconi, B; Uccella, Silvia; Bartalena, Luigi; Procopio, Fm; Accolla, Roberto; Capella, CARLO RENATO; Sessa, Fausto | |
| Ribonuclease T2 (RNASET2) expression in the spectrum of neuroendocrine neoplasms of the lung. Relationships with hypoxia-related mechanisms and microvascular patterns | 1-gen-2018 | Maragliano, R; Scaldaferri, D; Monti, L; Sorrenti, E; Gariboldi, M; Taramelli, R; Sessa, F; Acquati, F; La Rosa, S; Uccella, S | |
| Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells | 1-gen-2019 | Amodio, V; Grmano, G; Barault, L; Lamba, S; Rospo, G; Magri, A; Maione, F; Crisafulli, G; Cancelliere, C; Lerda, G; Bartolini, A; Siravegna, G; Mussolin, B; Frappolli, R; Montone, M; Randon, G; de Braud, F; Angelozzi, Na; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Satore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A | |
| microRNA-181a plays a critical role in ovarian cancer progression through the regulation of epithelial-mesenchymal transition | 1-gen-2013 | Parikh, A; Lee, C; Joseph, P; Marchini, S; Baccarini, A; Kolev, V; Romualdi, C; Fruscio, R; Shah, H; Feng, W; Mullokandov, G; Fishman, D; D'Incalci, M; Rahaman, J; Kalir, T; Redline, R; Brown, Bd; Narla, G; Difeo, A | |
| In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations | 1-gen-2014 | Algeri, M; Rosti, V; Zecca, M; Erba, E; Aronica, A; Galli, A; Zambelli, A; Strocchio, L; Tolva, A; Quartuccio, G; Mina, T; D'Incalci, M; DELLA PORTA, MATTEO GIOVANNI | |
| Lurbinectedin (PM01183): Antineoplastic Activity in Murine and Human Experimental Models | 1-gen-2012 | Fraoolli, R; Bello, E; Zangarini, M; Zucchetti, P; Aviles, P; D'Incalci, M | |
| HMGA1 is a new biomarker of liposarcoma progression | 1-gen-2017 | Loria, R; Laquintana, V; Bon, G; Trisciuoglio, D; Covello, R; Amoreo, Ca; Ferraresi, V; Zoccali, C; D'Incalci, M; Biagini, R; Falcioni, R | |
| Alpha 1 acid glycoprotein (AGP) binds to STI571 and substantially alters its pharmacokinetics in chronic myeloid leukemia (CML) patients | 1-gen-2001 | Gambacorti-Passeri, C; Zucchetti, M; Frapolli, R; Russo, D; Rossi, F; Pogliani, E; Corneo, G; Tornaghi, L; Alberti, D; D'Incalci, M | |
| Evaluation of the pan-BET-bromodomain inhibitor OTX015 as a single agent and in combination with everolimus (RAD001) in triple-negative breast cancer | 1-gen-2014 | Vazquez, R; Astorgues-Xerri, L; Riveiro, Me; Di Marino, M; Beltrame, L; Bekradda, M; Cvitkovic, E; Erba, E; Frapolli, R; D'Incalci, M | |
| SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY | 1-gen-2013 | Tancredi, R; Negri, S; Cattrini, C; Ponchio, L; Frascaroli, M; Daprada, G; Fregoni, V; Pavesi, L; Riccardi, A; Zucchetti, M; D'Incalci, M; Zambelli, A | |
| Induction of resistance to Aplidin((R)) in a human ovarian cancer cell line related to MDR expression | 1-gen-2006 | Tognon, G; Bernasconi, S; Celli, N; Faircloth, Gt; Cuevas, C; Jimeno, J; D'Incalci, M; Erba, E | |
| Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM) | 1-gen-2015 | Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P | |
| miRNA landscape analysis of stage I EOC, identifies miR-199a-5p associated to poor prognosis in grade 3 subgroup | 1-gen-2013 | Calura, E; Fruscio, R; Paracchini, L; Bignotti, E; Martini, P; Ravaggi, A; Di Marino, M; Sales, G; Beltrame, L; Dell'Orto, F; Baldo, R; Pecorelli, S; Sartori, E; Zanotti, L; Katsaros, D; Tognon, G; D'Incalci, M; Romualdi, C; Marchini, S | |
| EPOC-experiences - conducting a multinational clinical trial on the pharmacology of doxorubicin in children with cancer | 1-gen-2013 | Krischke, M; Andre, N; Boddy, A; Bode, G; D'Incalci, M; Hempel, G; Kontny, N; Steel, A; Voller, V; Boos, J | |
| Pharmacokinetics of concomitant cisplatin and paclitaxel administration by hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis | 1-gen-2013 | Ansaloni, L; Busci, Lm; Coccolini, F; Grosso, G; Lotti, M; Morosi, L; Poiasina, E; Zucchetti, M; D'Incalci, M; Frigerio, L | |
| RANDOMIZED, NON-COMPARATIVE, PHASE II TRIAL OF BEVACIZUMAB AND TRABECTEDIN WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE OVARIAN CANCER (ROC) WOMEN | 1-gen-2017 | Colombo, N; Nicoletto, Mo; Lissoni, A; Scambia, G; Tognon, G; Negri, E; Galli, F; Biagioli, E; Rulli, E; Fossati, R; D'Incalci, M | |
| AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER | 1-gen-2014 | Gerardi, C; Floriani, I; Biagioli, E; D'Incalci, M; Fossati, R; Colombo, N | |
| Fsn0503h antibody-mediated blockade of cathepsin S as potential therapeutic strategy for the treatment of solid tumors | 1-gen-2013 | Vazquez, R; Astorgues-Xerri, L; Cvitkovic, E; Bekradda, M; Fleck, R; Gormley, J; Buick, R; Kerr, P; Raymond, E; D'Incalci, M; Frapolli, R; Riveiro, Me |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...990
Data di pubblicazione
- 2020 - 202321
- 2010 - 2019515
- 2000 - 2009348
- 1990 - 199980
- 1980 - 198926
Editore
- s.n110
- sn21
- Società Italiana di Fisiologia7
- Monduzzi Editore5
- Springer5
- AMER SOC CLINICAL ONCOLOGY, 2318 ...3
- COFESE EDIZIONI PALERMO3
- Hungarian Society of Sport Science2
- IMECHE2
- ISAKOS2
Rivista
- ANNALS OF ONCOLOGY27
- JOURNAL OF CLINICAL ONCOLOGY22
- GASTROENTEROLOGY20
- EUROPEAN JOURNAL OF CANCER13
- JOURNAL OF CROHN'S AND COLITIS10
- KNEE SURGERY, SPORTS TRAUMATOLOGY...10
- NEURO-ONCOLOGY10
- EUROPEAN RESPIRATORY JOURNAL SUPP...8
- INTERNATIONAL JOURNAL OF GYNECOLO...7
- CANCER RESEARCH6
Serie
- IEEE ENGINEERING IN MEDICINE AND ...1
Keyword
- acl reconstruction11
- pneumonia8
- follow-up4
- knee4
- navigation system4
- ACL RECONSTRUCTION3
- CPAP3
- double bundle3
- failure3
- lca3
Lingua
- eng486
- ita173
- fre7
- und3
Accesso al fulltext
- no fulltext963
- reserved27